Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Rashmi R. Shetty"'
Autor:
Manjunath B. Joshi, Rashmi R. Shetty, Monica Shirley Mani, Venzil Lavie Dsouza, Shama Prasada Kabekkodu, Herman Sunil Dsouza, M Swathi
Publikováno v:
Toxicology Letters. 335:11-27
Lead is a toxin of great public health concern affecting the young and aging population. Several factors such as age, gender, lifestyle, dose, and genetic makeup result in interindividual variations to lead toxicity mainly due to variations in metabo
Publikováno v:
Journal of Laboratory Physicians, Vol 2, Iss 02, Pp 093-099 (2010)
Aim: Study was undertaken to analyze the frequency of anti-viral citrullinated peptide (anti-VCP) antibodies in sera from patients with early rheumatoid arthritis (ERA). Materials and Methods: Viral citrullinated peptide (VCP) and Epstein-Barr nuclea
Externí odkaz:
https://doaj.org/article/170772a523cc479b8ffecdc14b513470
Autor:
Reona Fernandes, Abdul Ghafur, Manjunatha Hande, John Preshanth Kumar Pathiraj, Archana Bhat, Vijayanarayana Kunhikatta, Swathi Naik, Mahadev Rao, Rashmi R. Shetty
Publikováno v:
Journal of Clinical Medicine
Volume 8
Issue 1
Journal of Clinical Medicine, Vol 8, Iss 1, p 84 (2019)
Volume 8
Issue 1
Journal of Clinical Medicine, Vol 8, Iss 1, p 84 (2019)
Antimicrobial resistance (AMR) is a recognized public health threat today globally. Although many active and passive stewardship strategies are advocated to counter AMR clinically, educating school going children on AMR could be a cost-effective meas
Publikováno v:
Annals of International medical and Dental Research. 3
Publikováno v:
Journal of Laboratory Physicians, Vol 2, Iss 02, Pp 093-099 (2010)
Journal of Laboratory Physicians
Journal of Laboratory Physicians
Aim: Study was undertaken to analyze the frequency of anti-viral citrullinated peptide (anti-VCP) antibodies in sera from patients with early rheumatoid arthritis (ERA). Materials and Methods: Viral citrullinated peptide (VCP) and Epstein-Barr nuclea
Publikováno v:
Experimental and clinical cardiology. 17(1)
Studies have shown that rheumatoid arthritis (RA) patients are two to five times more likely to develop premature cardiovascular disease, thus shortening their life expectancy by five to 10 years. This risk has risen to approximately 12.6% in the urb